Introducing the Practical Guideline for Diabetes and Ramadan, Developed by International Diabetes Federation in Collaboration with Diabetes and Ramadan International Alliance, 2016

M. Nematy, A. Mehdizadeh
{"title":"Introducing the Practical Guideline for Diabetes and Ramadan, Developed by International Diabetes Federation in Collaboration with Diabetes and Ramadan International Alliance, 2016","authors":"M. Nematy, A. Mehdizadeh","doi":"10.22038/JFH.2016.7588","DOIUrl":null,"url":null,"abstract":"Considering the fact that many Muslims with diabetes prefer to fast in spite of inhibitory advises and to answer several conflicts and controversies regarding diabetes and Ramadan, IDF in collaboration with Diabetes and Ramadan (DAR) International in Alliance decided to develop a comprehensive guideline to be used by health care professionals. This guideline was then developed on April 2016 by 12 main authors and 20 co-authors from all around the world, and published by International Diabetes Federation. The guideline is provided in nine chapters: 1) Introduction to the IDF-DAR Practical Guidelines, 2) Epidemiology of Diabetes and Ramadan Fasting, 3) Physiology of Ramadan Fasting, 4) Risk Stratification of Individuals with Diabetes before Ramadan, 5) Diabetes and Ramadan: A Medico-religious Perspective, 6) Pre-Ramadan Education, 7) Ramadan Nutrition Plan (RNP) for Patients with Diabetes, 8) Management of Diabetes during Ramadan and 9) Identifying and Overcoming Barriers to Guideline Implementation. This guideline tries to answer three main questions: 1) Is fasting during Ramadan associated with a significant risk? 2) What are the criteria that predispose patients with diabetes to increased risk during fasting? 3) What is the most appropriate oral anti-diabetic drug(s) or type and regimen of insulin for patients with type 2 diabetes who fast? IDF-DAR Practical Guideline is now available at: http://www.idf.org/sites/default/files/IDF-DAR-Practical-Guidelines-Final-Low.pdf","PeriodicalId":90593,"journal":{"name":"Journal of fasting and health","volume":"4 1","pages":"95-96"},"PeriodicalIF":0.0000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of fasting and health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22038/JFH.2016.7588","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Considering the fact that many Muslims with diabetes prefer to fast in spite of inhibitory advises and to answer several conflicts and controversies regarding diabetes and Ramadan, IDF in collaboration with Diabetes and Ramadan (DAR) International in Alliance decided to develop a comprehensive guideline to be used by health care professionals. This guideline was then developed on April 2016 by 12 main authors and 20 co-authors from all around the world, and published by International Diabetes Federation. The guideline is provided in nine chapters: 1) Introduction to the IDF-DAR Practical Guidelines, 2) Epidemiology of Diabetes and Ramadan Fasting, 3) Physiology of Ramadan Fasting, 4) Risk Stratification of Individuals with Diabetes before Ramadan, 5) Diabetes and Ramadan: A Medico-religious Perspective, 6) Pre-Ramadan Education, 7) Ramadan Nutrition Plan (RNP) for Patients with Diabetes, 8) Management of Diabetes during Ramadan and 9) Identifying and Overcoming Barriers to Guideline Implementation. This guideline tries to answer three main questions: 1) Is fasting during Ramadan associated with a significant risk? 2) What are the criteria that predispose patients with diabetes to increased risk during fasting? 3) What is the most appropriate oral anti-diabetic drug(s) or type and regimen of insulin for patients with type 2 diabetes who fast? IDF-DAR Practical Guideline is now available at: http://www.idf.org/sites/default/files/IDF-DAR-Practical-Guidelines-Final-Low.pdf
介绍2016年国际糖尿病联合会与糖尿病和斋月国际联盟合作制定的《糖尿病和斋月实用指南》
考虑到许多患有糖尿病的穆斯林不顾抑制性建议而宁愿斋戒,并为了回答关于糖尿病和斋月的一些冲突和争议,IDF与糖尿病和斋月国际联盟合作,决定制定一份供保健专业人员使用的综合指南。该指南由来自世界各地的12位主要作者和20位共同作者于2016年4月制定,并由国际糖尿病联合会出版。该指南共分为九章:1)IDF-DAR实用指南简介,2)糖尿病与斋月斋戒流行病学,3)斋月斋戒生理学,4)斋月前糖尿病患者的风险分层,5)糖尿病与斋月。医学-宗教视角;6)斋月前教育;7)糖尿病患者斋月营养计划(RNP); 8)斋月期间糖尿病的管理;9)确定并克服指南实施的障碍。本指南试图回答三个主要问题:1)斋月期间禁食与重大风险有关吗?2)糖尿病患者在禁食期间易患风险增加的标准是什么?3)空腹的2型糖尿病患者口服降糖药或胰岛素的种类和方案是什么?IDF-DAR实用指南现已在http://www.idf.org/sites/default/files/IDF-DAR-Practical-Guidelines-Final-Low.pdf上提供
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书